519. Deputy Gino Kenny asked the Minister for Health when a decision will be made by the HSE on the reimbursement of fenfluramine (fintepla) for the treatment of refractory epilepsy (details supplied); and if he will make a statement on the matter. [39728/24]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.